Using Epigenetic Therapy to Enhance Immunotherapy Response in RCC

Leigh Ellis Department of Oncologic Pathology Dana-Farber Cancer Institute Harvard Medical School presents Using Epigenetic Therapy to Enhance Immunotherapy Response in RCC

Filmed at the 18th International Kidney Cancer Symposium 2019, Miami, FL.